A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to H5N1 Vaccine in Adults
Conditions:   Influenza;   HealthyInterventions:   Biological: Multimeric 001 (M-001);   Biological: H5N1 influenza vaccine;   Biological: SalineSponsors:   BiondVax Pharmaceuticals ltd.;   Seventh Framework ProgrammeRecruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2016 Category: Research Source Type: clinical trials

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Condition:   A/Vietnam/H5N1 Influenza VirusInterventions:   Biological: 7.5 mcg H5N1 (stored as bulk);   Biological: 15 mcg H5N1 (stored as bulk);   Biological: 90 mcg H5N1 (stored as bulk);   Biological: 90 mcg H5N1 (stored in vials);   Other: MF59;   Other: MF59 (stored as bulk)Sponsors:   Biomedical Advanced Research and Development Authority;   PPDNot yet recruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2016 Category: Research Source Type: clinical trials